Baseimmune

Baseimmune is developing active immunotherapies for idiopathic pulmonary fibrosis (IPF). Using computational antigen design, Baseimmune engineers multi-target antigens that educate the immune system to generate coordinated antibody responses against multiple drivers of fibrosis, with the goal of transforming the treatment of chronic fibrotic disease.